On-Treatment HCV RNa As a Predictor of Sustained Virological Response in HCV Genotype 3-Infected Patients Treated With Daclatasvir and Sofosbuvir Academic Article
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1611
end page
- 1618
volume
- 36
number
- 11